Adenovirus-mediated kallikrein gene transfer inhibits neointima formation via increased production of nitric oxide in rat artery

Becker, 1994, Use of recombinant adenovirus for metabolic engineering of mammalian cells, Methods Cell Biol., 43, 161, 10.1016/S0091-679X(08)60603-2 Bhoola, 1992, Bioregulation of kinins: kallikreins, kininogens, and kininases, Pharmacol. Rev., 44, 1 Chao, 1998, Adenovirus-mediated kallikrein gene delivery attenuates hypertension, cardiac hypertension and renal injury in Dahl-salt sensitive rats, Hum. Gene Ther., 9, 21, 10.1089/hum.1998.9.1-21 Chen, 1998, Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery, Circ. Res., 82, 862, 10.1161/01.RES.82.8.862 Clowes, 1983, Mechanisms of stenosis after arterial injury, Lab. Invest., 49, 208 Dixon, 1996, Interaction between growth factors and kinins in arterial smooth muscle cells, Immunopharmacology, 33, 16, 10.1016/0162-3109(96)00076-8 Farhy, 1992, Kinins mediate the antiproliferative effect of ramipril in rat carotid artery, Biochem. Biophys. Res. Commun., 182, 283, 10.1016/S0006-291X(05)80142-1 Farhy, 1993, Role of kinins and nitric oxide in the effects of ACE inhibition on neointima formation, Circ. Res., 72, 1202, 10.1161/01.RES.72.6.1202 Garg, 1989, A nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells, J. Clin. Invest., 83, 1774, 10.1172/JCI114081 Huckle, 1994, Regulation of cell proliferation and growth by angiotensin II, Progress in Growth Factor Research, 5, 177, 10.1016/0955-2235(94)90004-3 Jin, 1997, Gene therapy in hypertension: adenovirus-mediated kallikrein gene therapy in hypertensive rats, Hum. Gene Ther., 8, 1753, 10.1089/hum.1997.8.15-1753 Kauffman, 1991, Losartan, a nonpeptide angiotensin II (ANGII) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries, Life Sci., 49, PL223, 10.1016/0024-3205(91)90298-P Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 Misko, 1993, A fluorometric assay for the measurement of nitrite in biological samples, Analytical Biochemistry, 214, 11, 10.1006/abio.1993.1449 Murakami, 1998, Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats, Kidney Int., 53, 1305, 10.1046/j.1523-1755.1998.00867.x Oza, 1990, Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity, J. Clin. Invest., 85, 597, 10.1172/JCI114479 Pauletto, 1994, Smooth-muscle-cell proliferation and differentiation in neointima formation and vascular restenosis, Clin. Sci., 87, 467, 10.1042/cs0870467 Powell, 1989, Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury, Science, 245, 186, 10.1126/science.2526370 Sharma, 1996, Blood pressure regulation by the kallikrein–kinin system, Gen. Pharmacol., 27, 55, 10.1016/0306-3623(95)00028-3 Wang, 1994, Human tissue kallikrein induces hypotension in transgenic mice, Hypertension, 23, 236, 10.1161/01.HYP.23.2.236 Wolf, 1999, Localization and expression of tissue kallikrein and kallistatin in human blood vessels, J. Histochem. Cytochem., 47, 221, 10.1177/002215549904700210 Yayama, 1998, Kallikrein gene delivery attenuates hypertension, cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats, Hypertension, 31, 1104, 10.1161/01.HYP.31.5.1104